Articles

iffering approaches for the treatment of coronary bifurcation and ostial lesions (CBOL) continue to feed the debate over which stent designs and stenting techniques are most effective.

When it comes to treating patients suffering from heart failure, which is typically defined as a heart whose pumping power is weaker than normal, physicians are facing a paradox.

Author’s Note: For this inaugural article I begin with an insider’s look on the “health” of drug-eluting stents and what lies ahead for this much-debated device.

New technologies adopted by cardiologists not only improve patient care but expand the role of these physicians. Whether it's stenting a carotid artery or viewing real-time ultrasound images at...

The long-standing standard of care for patients with carotid artery disease was surgery and/or medical management. In August 2004, the U.S. Food and Drug Administration changed all that when it...